June 23, 2016
NEW YORK (February 16, 2016) — An investigative therapy given to mice blocks the overactive immune responses that are a hallmark of inflammatory bowel disease without impairing the body's ability to fight infection, an international research team led by Weill Cornell Medicine investigators finds in a new study. The preclinical discovery may lead to more effective treatment strategies for IBD.
Continue to read at: http://weill.cornell.edu/news/news/2016/02/hed-innovative-therapeutic-ap...